New obesity pill begins human testing: is it safe?
NCT ID NCT06938269
Summary
This is the first human study of a new oral medication called MWN109 tablets, designed for weight management. Researchers will test the drug's safety, how the body processes it, and what side effects occur in 60 healthy adults with overweight or obesity. The study will start with single doses and progress to multiple doses, carefully monitoring participants for up to 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Veritus Research
NOT_YET_RECRUITINGBayswater, Victoria, 3153, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.